Amedeo's Top 20

Amedeo Smart

Independent Medical Education

10 July 2017

Multidisciplinary Journal Club

  1. Rolnik DL, Wright D, Poon LC, O'Gorman N, et al.
    Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
    N Engl J Med 2017.

  1. Leonard JP, Martin P, Roboz GJ.
    Practical Implications of the 2016 Revision of the World Health Organization Classification of Lymphoid and Myeloid Neoplasms and Acute Leukemia.
    J Clin Oncol 2017.

  2. Ketteler M, Block GA, Evenepoel P, Fukagawa M, et al.
    Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters.
    Kidney Int 2017;92:26-36.

  3. Torres HA, Hosry J, Mahale P, Economides MP, et al.
    Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study.
    Hepatology 2017.

  4. Easton JD, Aunes M, Albers GW, Amarenco P, et al.
    Risk for Major Bleeding in Patients Receiving Ticagrelor Compared with Aspirin After TIA or Acute Ischemic Stroke in the SOCRATES Study.
    Circulation 2017.

  1. Agopian VG, Harlander-Locke MP, Ruiz RM, Klintmalm GB, et al.
    Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients from the US Multicenter HCC Transplant Consortium.
    Ann Surg 2017.

  2. Abdel-Razeq H, Marei L, Saadeh SS, Abdulelah H, et al.
    From clinical trials to clinical practice: outcome of NSABP-B27 neoadjuvant chemotherapy regimen for high-risk early-stage breast cancer.
    Breast Cancer Res Treat 2017.

  3. Perino AC, Fan J, Schmitt SK, Askari M, et al.
    Treating Specialty and Outcomes in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.
    J Am Coll Cardiol 2017;70:78-86.

  4. Chen X, Chen H, Cai W, Maguire M, et al.
    The melanoma-linked "redhead" MC1R influences dopaminergic neuron survival.
    Ann Neurol 2017;81:395-406.

  5. Kaufmann H, Norcliffe-Kaufmann L, Palma JA, Biaggioni I, et al.
    Natural history of pure autonomic failure: A United States prospective cohort.
    Ann Neurol 2017;81:287-297.

  1. Chlebowski RT, Aragaki AK, Anderson GL, Thomson CA, et al.
    Low-Fat Dietary Pattern and Breast Cancer Mortality in the Women's Health Initiative Randomized Controlled Trial.
    J Clin Oncol 2017.

  2. Coleman CI, Peacock WF, Bunz TJ, Alberts MJ, et al.
    Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
    Stroke 2017.

  3. Russell MR, Graham C, D'Amato A, Gentry-Maharaj A, et al.
    A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours.
    Br J Cancer 2017.

  4. Spinelli EG, Mandelli ML, Miller ZA, Santos-Santos MA, et al.
    Typical and atypical pathology in primary progressive aphasia variants.
    Ann Neurol 2017;81:430-443.

  5. Descours B, Petitjean G, Lopez-Zaragoza JL, Bruel T, et al.
    Corrigendum: CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses.
    Nature 2017;546:686.

  1. Saha P, Regan MM, Pagani O, Francis PA, et al.
    Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials.
    J Clin Oncol 2017.

  2. Curigliano G, Criscitiello C.
    Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
    J Clin Oncol 2017.

  3. Derwa Y, Gracie DJ, Hamlin PJ, Ford AC, et al.
    Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease.
    Aliment Pharmacol Ther 2017.

  4. Lee MJ, Cha J, Choi HA, Woo SY, et al.
    Blood-brain barrier breakdown in reversible cerebral vasoconstriction syndrome: Implications for pathophysiology and diagnosis.
    Ann Neurol 2017;81:454-466.

  5. Nitz U, Gluz O, Christgen M, Kates RE, et al.
    Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial.
    Breast Cancer Res Treat 2017.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016